B
REPL icon

Braidwell’s Replimune Group REPL Stock Holding History

Braidwell’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,750,092
Closed -$11.5M – 82
2025
Q3 		$11.5M Buy
2,750,092
+2,327,205
+550% +$14.9M 0.34% 63
2025
Q2 		$3.93M Sell
422,887
-1,038,939
-71% -$9.07M 0.13% 52
2025
Q1 		$14.3M Sell
1,461,826
-15,276
-1% -$189K 0.5% 49
2024
Q4 		$17.9M Sell
1,477,102
-1,593,735
-52% -$19.4M 0.53% 53
2024
Q3 		$33.7M Buy
3,070,837
+2,057,460
+203% +$20.9M 0.95% 40
2024
Q2 		$9.12M Buy
+1,013,377
New +$7.06M 0.29% 60
2023
Q4 		– Sell
-487,520
Closed -$8.34M – 87
2023
Q3 		$8.34M Hold
487,520
– – 0.26% 81
2023
Q2 		$11.3M Buy
487,520
+413,855
+562% +$8.09M 0.37% 68
2023
Q1 		$1.3M Sell
73,665
-588,684
-89% -$14M 0.04% 79
2022
Q4 		$18M Buy
+662,349
New +$13.8M 0.6% 59

Other funds holding REPL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Braidwell's REPL Position: Q4 2025 in Review

Braidwell sold out of Replimune Group (REPL) in Q4 2025, closing a stake of 2,750,092 shares — an estimated $11.5M sold.

Braidwell first reported a position in REPL in Q4 2022 and held it in 10 quarters. The position peaked at $33.7M in Q3 2024. 164 funds tracked by Wall St. Rank hold REPL as of Q4 2025.

  • Braidwell reported no remaining Replimune Group position as of Q4 2025 after selling out during the quarter.
  • Braidwell sold 2,750,092 Replimune Group shares in Q4 2025, an estimated $11.5M.
  • Braidwell first reported a position in Replimune Group in Q4 2022 and held it in 10 quarters.
  • Braidwell's Replimune Group position peaked at $33.7M in Q3 2024.
  • 164 funds tracked by Wall St. Rank held Replimune Group as of Q4 2025.

Based on Braidwell's 13F filing for Q4 2025, filed 17 Feb 2026.